What’s the real promise of the spadin‑derived PE 22‑28 antidepressant?

Posted by kayla_s in Research & News - 3 points, 4 comments.

I just read the latest preclinical paper on PE 22‑28, the spadin‑derived peptide that blocks TREK‑1 channels. org/peptides/pe-22-28). For me, it’s exciting because it’s a different mechanism than the usual SSRIs, but the human data are still a long way off.

I’m curious what the community thinks about chasing a peptide that’s only got animal evidence so far, do you see a realistic path to human trials, or are we looking at a case of hype over early data? I’ve used noopept and adamax together for mood boosts, and the response was mild; would a TREK‑1 blocker change the game, or could it bring unforeseen side effects? What do you all think?

Comments

• reads_lifter: I’ve seen a few people jump on any peptide that shows antidepressant activity in mice, and it’s easy to get swept up in the hype. For me the noopept + adamax combo felt like a tweak, not a revolution – a little brighter focus but nothing that changed my mood that much. If a TREK‑1 blocker really works in humans it could be a fresh angle, but the same mice studies that show benefits also show seizure‑like spikes and trouble with blood pressure when the channel is fully shut down. I worry that “b
• kayla_s: Thanks for the heads‑up about the seizure‑like spikes and BP swings, reads_lifter. I’ve been just doing the 3 mg Noopept/2 mg Adamax combo for a couple of months with only a faint lift in focus and no mood change, so I totally get the “tweak” vibe you mentioned. If a TREK‑1 blocker does hit humans, I_FACTORY wonder if we can titrate it slowly to avoid the channel‐overkill and a trade‑off in blood pressure. Would you tweak the dose a bit or keep the spike‑risk in mind?
• ivy_mobility: I get that concern. In the mouse work, the peak dose that gave the biggest antidepressant‑like effect also produced the seizure spikes and BP rise. For me, if a TREK‑1 blocker ever reaches humans the key will be finding a sub‑inhibitory dose that tips the balance without tipping over. Do you think a step‑wise titration protocol would help_follow‑up 🚶‍♀️⚖️?
• kayla_s: I agree, the seizure and BP signal worries me too. I’m thinking a very low starting dose, maybe 1/10th of the mouse peak, then slowly bumping by 10‑20% every week while monitoring heart rate, blood pressure, and any tremor. Do you know what sort of bedside checks would be best for catching early neuro‑excitation? Also, if you’ve seen any human data on TREK‑1 blockers already, let me know.

Community discussion - research and educational context only. Not medical advice.